Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Lowenstein

Showing results (411-420 of 436) with videos related to

Pageof 44
Sort By:
Neoplasia (New York, N.Y.)|October 27, 2011
B cells are critical to T-cell-mediated antitumor immunity induced by a combined immune-stimulatory/conditionally cytotoxic therapy for glioblastomaMarianela Candolfi, James F Curtin, Kader Yagiz, et al.
Clinical Pharmacology and Therapeutics|February 19, 2010
Study of the efficacy, biodistribution, and safety profile of therapeutic gutless adenovirus vectors as a prelude to a phase I clinical trial for glioblastomaA K M G Muhammad, M Puntel, M Candolfi, et al.
Nature Communications|June 24, 2022
Spatiotemporal analysis of glioma heterogeneity reveals COL1A1 as an actionable target to disrupt tumor progressionAndrea Comba, Syed M Faisal, Patrick J Dunn, et al.
Neuro-Oncology|May 25, 2007
Optimization of adenoviral vector-mediated transgene expression in the canine brain in vivo, and in canine glioma cells in vitroMarianela Candolfi, G Elizabeth Pluhar, Kurt Kroeger, et al.
The Journal of Clinical Investigation|December 17, 2020
Inhibition of 2-hydroxyglutarate elicits metabolic reprogramming and mutant IDH1 glioma immunity in micePadma Kadiyala, Stephen V Carney, Jessica C Gauss, et al.
Nature Communications|October 19, 2022
P300 promotes tumor recurrence by regulating radiation-induced conversion of glioma stem cells to vascular-like cellsSree Deepthi Muthukrishnan, Riki Kawaguchi, Pooja Nair, et al.
Science Translational Medicine|March 4, 2016
ATRX loss promotes tumor growth and impairs nonhomologous end joining DNA repair in gliomaCarl Koschmann, Anda-Alexandra Calinescu, Felipe J Nunez, et al.
Nature|November 13, 2024
Foundation models for fast, label-free detection of glioma infiltrationAkhil Kondepudi, Melike Pekmezci, Xinhai Hou, et al.
Cell Reports|January 12, 2022
ATRX loss in glioma results in dysregulation of cell-cycle phase transition and ATM inhibitor radio-sensitizationTingting Qin, Brendan Mullan, Ramya Ravindran, et al.
Molecular Therapy. Oncology|May 22, 2026
Reprogramming the immune suppressive tumor microenvironment in glioma enhances the efficacy of immune-mediated gene therapyBrandon L McClellan, Jorge A Peña Agudelo, Anzar A Mujeeb, et al.
Pageof 44

Showing results (411-420 of 436) with videos related to

Sort By:
Pageof 44
Neoplasia (New York, N.Y.)|October 27, 2011
B cells are critical to T-cell-mediated antitumor immunity induced by a combined immune-stimulatory/conditionally cytotoxic therapy for glioblastomaMarianela Candolfi, James F Curtin, Kader Yagiz, et al.
Clinical Pharmacology and Therapeutics|February 19, 2010
Study of the efficacy, biodistribution, and safety profile of therapeutic gutless adenovirus vectors as a prelude to a phase I clinical trial for glioblastomaA K M G Muhammad, M Puntel, M Candolfi, et al.
Nature Communications|June 24, 2022
Spatiotemporal analysis of glioma heterogeneity reveals COL1A1 as an actionable target to disrupt tumor progressionAndrea Comba, Syed M Faisal, Patrick J Dunn, et al.
Neuro-Oncology|May 25, 2007
Optimization of adenoviral vector-mediated transgene expression in the canine brain in vivo, and in canine glioma cells in vitroMarianela Candolfi, G Elizabeth Pluhar, Kurt Kroeger, et al.
The Journal of Clinical Investigation|December 17, 2020
Inhibition of 2-hydroxyglutarate elicits metabolic reprogramming and mutant IDH1 glioma immunity in micePadma Kadiyala, Stephen V Carney, Jessica C Gauss, et al.
Nature Communications|October 19, 2022
P300 promotes tumor recurrence by regulating radiation-induced conversion of glioma stem cells to vascular-like cellsSree Deepthi Muthukrishnan, Riki Kawaguchi, Pooja Nair, et al.
Science Translational Medicine|March 4, 2016
ATRX loss promotes tumor growth and impairs nonhomologous end joining DNA repair in gliomaCarl Koschmann, Anda-Alexandra Calinescu, Felipe J Nunez, et al.
Nature|November 13, 2024
Foundation models for fast, label-free detection of glioma infiltrationAkhil Kondepudi, Melike Pekmezci, Xinhai Hou, et al.
Cell Reports|January 12, 2022
ATRX loss in glioma results in dysregulation of cell-cycle phase transition and ATM inhibitor radio-sensitizationTingting Qin, Brendan Mullan, Ramya Ravindran, et al.
Molecular Therapy. Oncology|May 22, 2026
Reprogramming the immune suppressive tumor microenvironment in glioma enhances the efficacy of immune-mediated gene therapyBrandon L McClellan, Jorge A Peña Agudelo, Anzar A Mujeeb, et al.
Pageof 44